Behind a veneer of accomplishment, underneath good grades and musical talents, Emily Chen was in disarray. She never knew what she was missing, perpetually cycling through potential mistakes in her mind in a desperate attempt not to slip up.

Every October is Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, an occasion to raise awareness and support for those with ADHD.

Supply of a common Adderall alternative is running low, further limiting options for US patients amid a national shortage of ADHD drugs that has lasted almost a year. Vyvanse, sold by Takeda Pharmaceutical Co., is in low inventory due to manufacturing issues, a company spokesperson told Bloomberg News.

Pavel Tabutov’s family had been invited to a gathering near his Los Angeles exurb home to hear a friend’s daughter perform with her singing group. But it wasn’t a great night to go out. His three young kids were cranky, and it would be a crowded social event where the kids would need to sit…

ADHD is a common mental disorder among children and adolescents. But often symptoms continue into adulthood, where it is underdiagnosed and undertreated. A late-stage diagnosis can be life-changing.

Computerized Progressive Attention Training (CPAT), a new treatment developed at Tel Aviv University, significantly improved the symptoms of 33 percent of students suffering from Attention Deficit Hyperactivity Disorder (ADHD).

CONFERENCE REPORTER: Researchers shared mixed good news for the novel treatment centanafadine for treating attention-deficit/hyperactivity disorder at the American Society of Health-System Pharmacists 2023 Summer Meetings and Exhibition.1 Specifically, they found centanafadine had a better safety profile and demonstrated more favorable tolerability but was less effective than lisdexamfetamine dimesylate (Vyvanse) for adults with ADHD.

[Excerpt] Now, a recent study from the Attention Deficit Hyperactivity Drugs Use Chronic Effects (ADDUCE) project, published in The Lancet, aimed to address these concerns by investigating the safety of methylphenidate in children and adolescents over a 2-year period. Technology Networks spoke with Dr. Sarah Inglis, trial manager for the ADDUCE study, to learn more about its findings…

The deficits are a “serious national security risk and could compromise” care.

Takeda Pharmaceutical Company Limited is facing a manufacturing delay for its ADHD drug, Vyvanse, just as shortages for other ADHD drugs roil the country.

Research has found those who use medications such as Ritalin without having conditions such as ADHD actually reduce their mental performance

(CNN) – Nearly 15% of children in the United States were recently treated for mental health disorders in 2021, according to new research from the US Centers for Disease Control and Prevention.